Figure 5.
Figure 5. Cleavage of human PAR-2 peptide by serine proteases. A peptide corresponding to region surrounding the cleavage site of human PAR-2 (32SSKGRSLIGKVDGT45) was incubated with the serine proteases PR3, HLE, and CG, and proteolytic fragments were analyzed by reverse chromatography, N-terminal sequencing, and mass spectrometry. The cleavage product of PR3 ended with a valine residue at position 42 (V42-D43), CG cleaved between lysine and valine (K41-V42), and HLE between isoleucine and glycine (I39-G40). Trypsin, a known activator of PAR-2, was used as a positive control.

Cleavage of human PAR-2 peptide by serine proteases. A peptide corresponding to region surrounding the cleavage site of human PAR-2 (32SSKGRSLIGKVDGT45) was incubated with the serine proteases PR3, HLE, and CG, and proteolytic fragments were analyzed by reverse chromatography, N-terminal sequencing, and mass spectrometry. The cleavage product of PR3 ended with a valine residue at position 42 (V42-D43), CG cleaved between lysine and valine (K41-V42), and HLE between isoleucine and glycine (I39-G40). Trypsin, a known activator of PAR-2, was used as a positive control.

Close Modal

or Create an Account

Close Modal
Close Modal